hg_79861.1

Basic information about the TSS

---

TSS ID: hg_79861.1 Species: human Chr: chr7		Start: 99325948 End: 99325959 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC054027 Distance: -8 GeneID: 10552 HGNC/MGI_ID: HGNC:703 UniProt_ID:

Gene_name: actin related protein 2/3 complex subunit 1A Gene_symbol: ARPC1A Gene_synonyms: Arc40 SOP2Hs SOP2L Gene_source: HGNC:703

TATA-Box annotation

---

Distance to TSS:	56
Nearest PromoterID:	NM_006409
Entrez ID:	10552
Nearest Unigene:	Hs.124126
Nearest Refseq:	NM_006409
Nearest Ensembl:	ENSG00000241685
Gene Name:	actin related protein 2/3 complex subunit 1A
Gene Alias:	Arc40|HEL-68|HEL-S-307|SOP2Hs|SOP2L
Gene Description:	actin related protein 2/3 complex subunit 1A
Gene Type:	protein-coding
CpG%:	0.13
GC%:	0.706468
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ARPC1A p2@ARPC1A p3@ARPC1A p4@ARPC1A
Sample		p1@ARPC1A	p2@ARPC1A	p3@ARPC1A	p4@ARPC1A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	71.69	5.26	5.26	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	75.87	5.66	3.44	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	71.57	4.82	3.09	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	66.74	3.95	3.53	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	66.59	2.70	3.37	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	65.51	4.46	2.52	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	100.01	3.70	3.27	2.40
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	84.05	5.33	4.12	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	83.56	5.56	3.85	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	57.38	4.06	3.48	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	57.81	5.66	2.43	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	62.61	5.69	3.25	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	88.49	2.10	1.93	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	83.90	2.26	1.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	91.33	3.07	1.32	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	92.30	1.76	1.01	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	77.75	2.62	2.62	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	86.05	2.53	3.37	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	69.84	2.67	1.60	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	79.88	1.50	1.96	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	82.06	1.74	1.07	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	87.87	2.42	1.55	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	85.18	1.94	1.55	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	81.29	1.70	2.43	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	78.43	2.32	2.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	70.27	2.85	1.58	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	77.47	1.10	2.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	90.53	4.01	1.89	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	88.51	4.04	2.26	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	93.74	3.08	0.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	86.25	1.67	2.93	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	87.73	1.37	0.39	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	96.23	2.32	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	102.59	5.44	1.32	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	85.83	2.80	1.12	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	84.89	1.34	1.53	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	94.42	1.02	1.64	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	89.46	3.83	2.22	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	98.05	5.13	2.70	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	93.38	1.44	1.20	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	94.10	2.12	2.82	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	93.40	3.51	1.90	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	91.95	2.74	1.69	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	107.69	2.27	3.50	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	99.78	3.61	2.21	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	90.27	3.95	1.16	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	104.12	1.68	3.36	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	92.10	2.38	1.19	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	103.17	2.63	2.15	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	89.98	1.82	2.22	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	90.38	1.84	2.25	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	95.18	2.67	2.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	104.68	2.84	3.19	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	92.46	3.31	3.31	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	102.35	6.71	2.52	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	93.23	5.51	2.30	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	103.07	1.94	3.89	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	97.64	1.93	3.53	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	100.27	3.77	2.83	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	112.81	2.12	2.12	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	104.87	3.36	2.24	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	72.45	3.18	3.98	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	83.92	3.06	3.40	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	120.55	4.55	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	115.37	3.19	3.19	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	115.54	2.44	1.95	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	132.40	3.97	2.98	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	101.80	7.04	3.75	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	95.71	2.32	3.64	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	107.34	3.71	2.47	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	121.07	4.59	2.14	2.14
Adipocyte - breast, donor1	11376-118A8	95.19	3.17	2.53	0.48
Adipocyte - breast, donor2	11327-117E4	67.06	1.44	2.73	0.00
Adipocyte - omental, donor1	11473-119C6	87.79	4.07	2.29	0.64
Adipocyte - omental, donor2	11474-119C7	75.50	3.74	2.24	1.49
Adipocyte - omental, donor3	11475-119C8	65.64	1.00	2.68	0.00
Adipocyte - perirenal, donor1	11476-119C9	88.68	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	48.38	2.20	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	117.42	2.71	1.35	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	87.58	1.74	2.43	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	65.13	0.78	1.96	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	37.32	0.00	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	54.36	1.39	1.95	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	39.97	1.18	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	67.00	1.77	1.61	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	51.00	0.97	1.61	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	45.85	1.07	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	52.31	0.00	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	70.29	0.83	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	44.96	0.75	1.51	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	48.43	1.96	0.98	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	47.80	0.61	1.52	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	174.81	5.52	6.63	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	119.05	1.79	5.02	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	105.43	2.40	5.99	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	150.40	3.60	6.12	1.62
Amniotic Epithelial Cells, donor2	11613-122A2	117.14	1.67	5.02	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	114.02	3.70	2.88	0.21
Anulus Pulposus Cell, donor1	11248-116E6	139.37	6.18	2.98	1.03
Anulus Pulposus Cell, donor2	11463-119B5	127.11	2.69	4.90	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	102.44	2.70	3.15	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	113.31	4.34	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	98.45	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	117.18	2.99	2.69	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	149.23	2.53	6.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	89.77	0.66	3.96	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	91.29	1.95	0.97	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	102.91	2.91	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	96.21	1.78	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	102.82	4.52	1.51	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	95.06	6.53	7.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	71.47	2.51	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	126.85	2.97	2.47	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	125.56	1.36	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	100.43	2.87	3.17	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	103.94	3.21	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	108.45	3.40	1.89	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	110.66	0.80	2.67	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	113.15	0.98	4.88	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	99.85	3.65	2.65	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	87.65	2.40	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	120.37	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	102.06	1.72	2.40	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	67.12	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	108.25	4.37	2.91	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	118.01	1.90	3.42	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	93.28	2.42	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	112.87	3.42	3.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	105.82	2.57	3.21	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	98.59	2.06	3.36	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	101.82	2.35	2.82	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	110.93	2.89	3.54	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	100.60	2.14	2.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	90.67	2.92	4.68	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	126.15	2.71	4.52	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	103.36	3.56	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	99.68	1.53	4.58	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	114.10	1.53	2.29	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	88.95	2.54	2.54	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	108.75	3.45	3.45	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	104.36	3.81	2.75	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	101.49	0.87	2.03	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	121.87	0.94	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	99.00	1.86	2.88	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	81.07	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	111.97	0.00	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	99.27	2.79	3.22	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	105.89	3.61	3.01	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	117.37	4.37	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	90.57	2.76	2.30	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	114.76	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	109.07	4.58	2.29	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	109.41	3.92	2.27	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	103.12	1.22	1.22	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	108.03	1.43	3.82	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	109.32	2.00	2.66	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	80.87	4.58	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	91.95	1.66	3.88	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	95.59	2.91	3.44	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	106.13	3.27	2.18	0.36
Astrocyte - cerebellum, donor1	11500-119F6	165.31	5.04	5.04	1.11
Astrocyte - cerebellum, donor2	11580-120F5	159.18	1.88	4.11	1.20
Astrocyte - cerebellum, donor3	11661-122F5	91.87	1.26	3.36	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	113.29	3.14	4.18	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	130.71	2.43	2.91	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	112.32	2.24	2.39	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	52.76	1.83	1.95	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	56.25	2.26	2.88	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	50.87	1.82	1.48	0.46
Basophils, donor1	12241-129G9	30.34	2.09	0.78	0.00
Basophils, donor2	12242-129H1	34.28	1.80	1.80	0.00
Basophils, donor3	12243-129H2	32.49	1.03	2.65	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	105.86	3.88	2.16	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	104.24	2.74	1.37	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	129.12	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	114.86	4.39	5.02	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	111.88	2.70	3.12	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	117.45	2.53	3.22	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	85.47	3.24	1.62	1.26
Burkitt's lymphoma cell line:DAUDI	10422-106C8	139.43	4.74	5.46	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	169.32	2.10	8.38	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	42.85	1.28	1.92	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	30.43	1.69	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	34.71	1.11	0.74	0.00
CD14+ Monocytes, donor3	11381-118B4	37.76	1.32	1.10	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	64.25	1.13	0.57	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	50.04	2.27	1.14	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	61.80	1.31	1.97	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	72.71	3.32	0.87	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	54.62	1.21	0.91	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	58.75	0.24	1.42	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	57.58	1.51	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.30	0.55	0.83	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	42.15	1.24	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	61.48	1.17	1.37	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	54.66	1.25	1.60	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	42.66	2.61	0.65	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	38.40	0.70	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	46.47	0.53	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	28.84	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	58.76	1.93	1.19	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	52.88	2.00	0.60	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	45.60	1.25	1.87	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	49.88	0.92	0.69	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	38.91	1.58	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	34.92	0.87	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	60.25	1.34	1.34	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	67.17	3.66	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	70.28	1.68	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	51.62	1.84	0.92	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	55.31	2.47	1.76	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	52.65	0.44	0.88	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	59.11	0.87	1.57	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	41.63	0.74	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	47.85	1.08	1.29	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	50.37	0.82	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	36.62	2.09	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	38.28	0.46	0.93	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	43.37	2.40	2.18	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	51.51	1.62	2.08	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	50.04	1.08	0.87	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	50.77	1.40	1.09	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	36.50	1.22	1.05	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	46.15	1.34	0.89	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	61.24	1.79	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	51.38	2.85	1.54	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	64.64	2.74	1.05	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	60.97	2.03	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	50.17	0.00	2.71	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	49.71	3.11	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	41.58	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	46.64	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	49.14	0.70	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	51.77	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	46.14	1.32	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	43.56	0.00	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	37.72	1.45	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	45.43	1.01	2.52	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	117.98	1.21	5.66	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	104.27	2.40	3.20	0.00
CD34+ Progenitors, donor1	11545-120B6	27.11	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	34.27	0.56	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	49.98	1.13	1.88	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	51.64	2.03	0.90	0.00
CD4+ T Cells, donor1	11225-116C1	66.41	0.71	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	48.38	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	51.54	0.30	0.91	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	47.98	0.51	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	52.33	1.12	1.12	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	52.61	1.15	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	43.14	0.47	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	49.16	0.70	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	43.64	1.30	1.01	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	45.59	1.36	0.51	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	49.65	1.13	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	50.21	0.45	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	49.96	1.05	1.75	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	42.24	0.44	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.06	0.42	1.26	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	43.42	1.66	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.09	1.34	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	54.11	0.82	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	68.07	1.07	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	46.62	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	44.87	1.85	1.11	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	45.27	0.87	1.30	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	59.05	1.47	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	45.00	0.51	1.52	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	38.13	0.87	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.27	1.31	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.94	0.49	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	66.47	0.92	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	44.67	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	56.22	0.55	1.11	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	65.76	0.74	0.98	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	49.28	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	65.18	0.72	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	73.40	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	44.85	0.65	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	44.30	0.75	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	55.55	1.01	1.26	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	34.41	2.06	0.69	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.75	1.44	0.48	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	45.42	2.74	0.55	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	49.53	2.70	0.00	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	39.36	1.92	1.68	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.97	2.50	1.14	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	39.55	2.17	1.09	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	35.01	1.58	0.53	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	42.21	1.17	1.17	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	41.06	2.42	1.51	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	31.37	2.32	1.16	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	32.77	2.66	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	25.83	2.19	0.88	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.07	1.37	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	26.11	0.00	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	43.58	2.88	0.72	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	41.72	1.44	1.44	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	37.48	1.41	0.94	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	48.80	2.22	0.63	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	45.52	1.23	1.54	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	44.24	2.56	0.32	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	37.86	1.91	1.91	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	33.50	2.36	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	35.55	3.03	2.27	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	53.00	1.61	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	50.36	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	47.08	1.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	51.18	1.83	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	114.13	5.93	3.95	0.49
Cardiac Myocyte, donor3	11686-122I3	130.91	6.31	2.00	1.37
Chondrocyte - de diff, donor1	11261-116G1	165.71	5.55	6.59	1.04
Chondrocyte - de diff, donor2	11338-117F6	82.09	2.49	2.49	0.36
Chondrocyte - de diff, donor3	11410-118E6	77.94	2.96	1.02	0.46
Chondrocyte - re diff, donor2	11339-117F7	171.89	7.16	4.48	0.90
Chondrocyte - re diff, donor3	11411-118E7	76.03	3.64	1.62	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	147.81	5.16	3.56	1.61
Ciliary Epithelial Cells, donor2	11323-117D9	116.50	2.57	3.63	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	131.68	4.25	3.19	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	85.19	5.87	2.20	1.93
Corneal Epithelial Cells, donor1	11526-119I5	125.60	6.37	2.63	0.66
Corneal Epithelial Cells, donor2	11606-120I4	105.80	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	139.57	6.65	3.07	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	37.97	0.66	0.00	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	30.59	3.15	0.00	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	29.59	1.30	0.11	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	46.12	1.02	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	42.44	1.31	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	45.01	0.48	2.90	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	159.26	7.67	3.34	1.33
Endothelial Cells - Aortic, donor1	11263-116G3	139.07	1.76	2.35	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	134.05	4.24	1.70	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	182.44	1.97	3.15	1.18
Endothelial Cells - Artery, donor1	11264-116G4	132.35	5.24	1.45	0.58
Endothelial Cells - Artery, donor2	11341-117F9	127.29	4.71	1.88	0.94
Endothelial Cells - Artery, donor3	11413-118E9	164.97	6.49	4.03	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	105.06	2.44	1.77	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	128.71	2.13	2.74	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	112.48	1.97	0.85	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	113.21	2.67	1.78	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	109.86	4.17	2.08	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	93.44	2.41	1.42	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	169.65	6.40	4.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	94.34	2.62	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	192.83	6.59	3.35	1.49
Endothelial Cells - Umbilical vein, donor2	11324-117E1	95.81	2.39	1.30	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	118.10	2.44	3.05	0.85
Endothelial Cells - Vein, donor1	11267-116G7	142.19	4.55	5.69	1.14
Endothelial Cells - Vein, donor2	11344-117G3	173.23	5.59	6.29	1.40
Endothelial Cells - Vein, donor3	11416-118F3	177.73	4.55	1.88	0.63
Eosinophils, donor1	12244-129H3	76.23	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	84.16	4.95	0.00	0.00
Eosinophils, donor3	12246-129H5	46.37	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	96.51	4.64	2.93	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	99.85	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	105.09	4.52	2.05	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	103.69	2.63	2.63	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	208.01	6.18	4.77	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	154.03	7.40	2.30	1.33
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	44.90	6.41	1.91	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	118.13	3.80	2.00	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	37.42	4.22	0.53	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	170.42	6.31	2.99	0.66
Fibroblast - Cardiac, donor1	11268-116G8	105.70	7.26	3.18	0.45
Fibroblast - Cardiac, donor2	11345-117G4	102.32	6.06	2.27	0.76
Fibroblast - Cardiac, donor3	11417-118F4	81.54	2.84	1.26	0.63
Fibroblast - Cardiac, donor4	11452-119A3	117.00	2.42	1.82	0.30
Fibroblast - Cardiac, donor5	11456-119A7	111.93	2.54	2.28	1.27
Fibroblast - Cardiac, donor6	11460-119B2	138.25	3.64	3.49	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	135.46	2.68	3.62	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	88.87	2.59	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	117.18	5.86	8.79	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	233.87	16.14	5.07	3.46
Fibroblast - Conjunctival, donor3	11692-122I9	143.49	3.22	2.88	0.34
Fibroblast - Dermal, donor1	11269-116G9	138.52	5.17	2.58	1.17
Fibroblast - Dermal, donor2	11346-117G5	171.69	5.19	7.55	0.00
Fibroblast - Dermal, donor3	11418-118F5	154.86	4.11	2.30	0.85
Fibroblast - Dermal, donor4	11450-119A1	168.32	5.31	4.75	1.36
Fibroblast - Dermal, donor5	11454-119A5	156.83	4.01	4.54	1.22
Fibroblast - Dermal, donor6	11458-119A9	189.39	5.04	5.36	0.97
Fibroblast - Gingival, donor1	11237-116D4	170.33	6.66	2.50	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	144.62	4.98	2.10	0.79
Fibroblast - Gingival, donor2	11318-117D4	187.92	5.80	4.61	1.32
Fibroblast - Gingival, donor3	11394-118C8	138.65	3.87	2.42	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	74.80	8.31	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	59.20	1.59	1.41	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	139.22	4.83	4.21	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	167.28	4.33	4.60	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	92.45	2.47	4.59	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	133.23	2.63	4.09	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	129.54	4.50	3.68	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	123.19	5.59	3.40	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	105.07	2.20	2.35	0.29
Fibroblast - Lung, donor1	11270-116H1	144.09	2.72	5.44	0.00
Fibroblast - Lung, donor2	11347-117G6	182.04	8.95	5.97	1.49
Fibroblast - Lung, donor3	11419-118F6	181.49	5.70	3.17	2.74
Fibroblast - Lymphatic, donor1	11506-119G3	263.23	3.33	7.50	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	149.65	0.00	5.59	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	84.80	0.84	1.12	0.56
Fibroblast - Mammary, donor1	11540-120B1	273.62	6.90	7.31	2.03
Fibroblast - Mammary, donor2	11620-122A9	187.73	0.00	15.98	0.00
Fibroblast - Mammary, donor3	11701-123A9	119.13	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	214.15	6.98	5.43	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	202.34	4.55	5.92	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	190.63	7.34	6.12	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	111.05	4.20	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	103.95	3.78	2.70	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	58.57	1.51	0.93	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	131.31	4.75	3.09	1.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	175.15	4.06	4.88	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	177.07	4.68	3.34	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	109.12	1.98	2.77	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	49.22	4.17	2.98	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	81.17	1.78	1.60	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	120.62	6.11	2.96	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	46.33	2.71	1.50	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	158.69	6.05	3.89	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	41.25	6.33	1.27	0.00
Fibroblast - skin normal, donor1	11553-120C5	123.39	3.45	3.12	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	60.95	6.82	1.40	2.01
Fibroblast - skin normal, donor2	11561-120D4	157.73	4.92	5.73	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	50.78	5.44	3.93	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	109.27	2.65	2.15	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	120.01	3.59	1.54	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	57.80	1.97	2.63	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	132.30	4.58	3.94	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	159.91	5.06	4.72	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	133.92	4.23	3.29	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	86.28	1.74	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	142.50	7.97	4.16	1.73
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	132.20	5.47	4.68	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	97.86	3.58	3.58	1.79
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	101.05	5.36	4.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	128.89	6.38	2.55	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	113.25	5.13	4.85	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	131.81	4.14	6.89	3.03
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	91.56	1.60	5.25	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	108.77	2.77	3.37	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	125.56	2.91	3.17	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	94.26	2.28	4.57	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	95.08	3.54	3.54	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	119.70	4.66	3.67	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	111.07	4.93	3.45	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	98.05	2.42	4.84	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	115.96	4.83	3.59	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	119.32	5.12	4.57	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	99.82	3.25	4.47	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	103.82	3.65	2.28	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	104.76	2.99	3.61	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	104.70	1.53	2.84	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	95.14	4.14	4.14	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	110.79	3.81	4.13	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	98.53	3.57	4.02	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	99.61	2.62	3.02	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	111.96	4.07	2.54	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	116.25	4.26	3.64	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	92.92	4.06	2.08	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	86.24	3.42	2.22	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	102.80	4.43	2.10	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	102.00	4.74	3.08	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	91.06	4.70	3.47	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	81.70	2.68	1.44	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	99.73	3.23	3.46	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	81.55	3.50	3.50	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	80.24	3.53	2.87	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	114.51	6.52	2.34	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	79.59	3.73	2.11	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	87.23	4.17	2.25	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	89.83	3.79	3.13	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	78.93	2.21	1.27	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	82.10	2.13	2.13	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	89.28	3.45	1.78	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	88.26	2.85	1.54	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	78.27	5.33	1.40	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	91.48	4.35	2.13	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	93.59	2.67	2.14	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	88.90	3.83	3.37	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	98.32	4.53	2.98	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	103.55	3.80	2.71	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	84.62	2.95	2.77	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	84.00	3.73	1.97	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	114.05	1.98	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	75.85	3.03	3.03	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	74.25	3.23	2.42	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	98.11	4.83	2.54	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	112.67	4.18	4.78	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	102.61	4.47	3.54	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	132.37	7.36	5.11	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	116.72	4.38	5.63	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	121.78	7.06	5.37	3.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	122.68	7.38	6.46	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	113.84	2.47	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	102.12	7.35	5.03	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	101.08	1.60	6.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	109.55	5.22	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	91.46	6.51	2.93	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	97.19	3.29	5.35	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	73.31	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	86.13	4.47	3.08	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	92.17	4.58	2.94	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	89.76	4.19	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	105.60	4.77	3.18	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	100.88	4.08	2.72	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	96.05	2.09	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	113.97	5.15	4.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	104.48	4.14	2.37	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	67.77	8.47	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	105.62	5.38	3.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	98.73	5.75	3.45	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	147.52	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	83.03	2.69	1.92	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	91.27	2.61	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	93.64	2.68	4.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	103.64	5.39	1.54	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	107.84	6.16	3.77	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	91.94	0.00	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	114.19	1.89	4.25	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	93.54	1.21	4.22	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	118.01	4.07	3.05	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	102.10	1.99	1.99	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	97.19	7.40	1.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	107.42	3.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	110.85	4.08	3.50	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	95.24	3.07	1.76	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	79.68	3.39	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	96.70	5.37	2.39	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	88.80	2.91	2.91	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	81.03	0.00	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	57.80	0.83	2.08	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	174.29	2.25	6.75	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	90.71	1.27	3.17	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	105.27	1.67	2.09	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	79.02	2.32	3.37	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	76.80	1.69	5.74	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	68.02	2.50	4.32	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	85.37	2.30	4.04	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	75.00	3.65	4.51	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	66.74	1.94	2.37	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	77.46	2.24	3.24	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	69.65	1.72	5.49	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	65.68	4.16	2.56	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	146.06	2.24	3.36	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	149.31	2.16	4.33	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	118.97	0.00	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	137.91	5.29	2.12	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	124.96	5.09	3.63	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	108.75	4.90	2.80	2.45
Hepatocyte, donor1	11523-119I2	56.90	1.21	4.84	0.00
Hepatocyte, donor2	11603-120I1	52.79	2.15	1.08	0.00
Hepatocyte, donor3	11684-122I1	53.38	0.61	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	42.42	0.65	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	154.33	7.17	6.12	2.27
Iris Pigment Epithelial Cells, donor1	11530-119I9	117.04	2.88	3.57	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	46.13	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	47.11	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	5.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	47.64	1.32	2.65	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	32.15	4.43	4.43	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	20.95	15.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	49.13	6.30	1.89	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	44.85	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	51.68	5.17	4.52	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	33.81	3.22	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	47.26	5.70	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	30.65	6.30	4.20	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	52.24	3.21	4.02	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	44.32	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	50.04	6.61	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	24.49	0.91	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	49.50	5.38	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	35.57	3.81	5.08	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	43.36	3.19	4.46	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	36.45	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	39.27	4.28	5.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	52.78	2.78	3.09	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	1.76	3.51	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	3.14	3.14	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	38.94	3.48	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	53.11	4.43	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	3.24	9.73	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	60.16	6.98	1.74	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	67.49	0.00	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	60.81	6.40	4.27	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	42.74	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	56.15	1.84	4.60	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	69.58	6.05	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	53.93	4.23	5.29	2.11
Keratinocyte - epidermal, donor1	11272-116H3	112.53	5.30	4.90	1.06
Keratinocyte - epidermal, donor2	11349-117G8	71.45	4.69	6.44	0.59
Keratinocyte - epidermal, donor3	11421-118F8	125.32	7.10	3.03	1.14
Keratinocyte - oral, donor1	11251-116E9	124.07	8.51	2.04	1.70
Keratocytes, donor1	11527-119I6	170.20	7.22	3.78	0.69
Keratocytes, donor2	11607-120I5	169.91	5.86	3.52	1.17
Keratocytes, donor3	11688-122I5	91.49	1.38	1.38	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	48.35	0.00	6.59	0.00
Lens Epithelial Cells, donor1	11529-119I8	112.19	9.71	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	133.44	2.65	2.88	0.35
Lens Epithelial Cells, donor3	11690-122I7	97.48	4.14	2.93	0.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	95.93	4.51	1.78	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	75.07	2.23	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	106.88	3.62	1.89	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	75.82	1.61	2.15	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	84.46	3.15	1.89	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	96.60	2.37	2.80	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	75.51	2.05	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	87.48	3.79	2.02	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	86.84	1.97	1.69	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	73.96	1.19	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	79.69	2.52	0.97	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	83.87	3.33	1.48	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	71.78	3.83	2.09	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	92.31	3.34	0.95	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	94.22	3.98	1.24	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	80.38	1.54	0.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	68.90	1.56	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	101.01	1.83	1.46	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	71.75	2.30	3.29	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	79.08	3.51	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	89.86	4.23	1.00	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	63.53	4.85	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	74.33	3.50	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	90.52	4.24	0.61	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	74.13	1.56	3.11	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	76.22	2.51	2.30	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	95.64	3.91	1.65	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	83.23	2.75	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	77.14	4.52	1.32	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	95.00	3.18	1.06	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	79.96	1.94	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	76.74	3.31	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	90.69	2.85	1.61	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	82.56	1.48	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	67.21	3.21	1.24	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	89.65	3.30	1.10	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	79.77	2.89	1.29	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	79.13	3.04	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	101.06	2.24	1.68	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	77.16	2.13	0.71	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	64.48	1.45	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	93.21	4.67	0.62	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	77.35	2.51	1.07	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	75.79	3.59	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	92.05	4.00	0.71	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	97.39	5.20	1.36	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	77.61	4.61	0.51	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	82.35	4.18	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	108.77	4.53	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	130.41	3.07	9.97	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	113.56	2.23	7.42	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	123.13	2.96	4.65	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	112.53	4.22	7.03	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	125.15	3.74	2.80	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	120.57	2.58	6.18	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	107.05	3.57	5.95	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	136.85	4.30	4.52	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	135.53	3.78	7.85	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	131.00	4.05	9.00	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	149.98	4.20	7.45	1.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	120.68	4.11	6.68	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	131.26	2.12	8.82	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	111.94	6.00	8.66	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	115.63	2.55	7.64	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	131.54	2.93	8.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	136.04	4.16	6.80	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	111.05	1.23	4.29	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	162.27	3.26	6.52	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	141.40	4.79	8.75	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	133.96	3.64	7.85	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	125.70	2.06	10.30	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	130.35	4.06	6.97	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	130.33	3.29	7.17	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	122.82	3.87	8.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	138.92	4.95	11.31	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	134.60	4.79	7.01	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	127.79	2.30	8.06	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	141.22	3.45	6.52	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	121.15	5.66	5.10	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	140.30	7.38	7.38	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	138.28	4.52	7.68	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	124.96	5.03	12.21	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	150.13	2.99	5.98	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	142.69	4.09	8.92	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	127.07	4.74	7.32	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	148.14	2.57	7.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	139.27	2.00	5.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	129.11	0.60	6.03	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	120.87	4.27	5.69	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	134.74	3.78	6.53	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	107.35	5.37	5.90	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	110.43	5.39	10.77	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	139.64	3.33	6.30	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	95.36	4.65	6.98	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	117.41	4.23	9.52	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	131.65	3.20	6.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	97.40	2.91	8.72	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	151.77	6.13	10.73	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	129.73	5.43	12.33	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	100.68	2.82	8.47	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	135.26	5.03	6.03	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	136.54	3.15	5.86	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	118.76	6.88	8.61	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	133.16	2.23	7.57	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	128.65	3.52	7.82	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	96.32	3.96	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	122.47	2.59	8.82	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	114.64	2.19	6.56	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	123.56	4.47	8.39	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	121.45	5.30	7.07	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	128.44	4.24	5.79	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	128.11	4.05	11.14	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	130.73	6.73	7.69	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	144.31	5.17	9.94	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	128.82	3.04	8.51	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	127.27	3.46	9.68	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	125.40	3.04	7.98	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	114.13	2.58	7.75	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	104.61	6.05	4.84	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	125.18	6.02	6.97	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	114.61	5.86	8.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	120.11	3.45	4.02	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	121.87	3.09	6.17	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	126.62	5.66	11.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	125.98	1.70	7.38	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	132.71	3.33	7.49	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	124.50	9.40	7.05	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	134.45	5.43	6.68	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	124.52	3.72	6.04	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	112.40	4.68	6.02	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	153.44	4.81	9.62	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	128.10	4.04	6.87	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	90.86	6.42	6.42	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	119.14	5.33	5.33	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	144.75	4.56	9.12	3.99
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	127.31	1.53	9.20	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	154.30	6.02	7.11	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	141.65	4.01	7.57	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	135.18	4.42	7.80	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	163.12	5.97	5.97	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	166.29	6.24	12.47	0.00
Macrophage - monocyte derived, donor1	11232-116C8	42.85	0.91	0.91	0.23
Macrophage - monocyte derived, donor2	11313-117C8	30.65	1.10	0.73	0.00
Macrophage - monocyte derived, donor3	11389-118C3	42.08	1.18	0.79	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	109.39	4.25	4.78	0.53
Mallassez-derived cells, donor2	11929-125I3	94.91	4.60	2.85	0.00
Mallassez-derived cells, donor3	11930-125I4	117.58	5.14	3.20	0.97
Mammary Epithelial Cell, donor1	11273-116H4	122.76	14.45	1.40	2.49
Mammary Epithelial Cell, donor2	11350-117G9	105.11	8.11	1.74	3.47
Mammary Epithelial Cell, donor3	11422-118F9	117.98	4.74	1.50	0.50
Mast cell - stimulated, donor1	11487-119E2	65.76	2.71	1.36	0.68
Mast cell, donor1	11563-120D6	45.85	1.62	0.87	0.32
Mast cell, donor2	11565-120D8	22.29	0.89	0.59	0.30
Mast cell, donor3	11566-120D9	20.71	0.23	0.23	0.00
Mast cell, donor4	11567-120E1	25.00	0.35	0.71	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	56.33	1.11	1.44	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	43.19	0.58	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	50.36	0.69	0.92	0.46
Mast cell, expanded, donor8	11941-126A6	30.29	0.50	0.84	0.00
Melanocyte - dark, donor1	11502-119F8	123.08	2.98	1.89	0.10
Melanocyte - dark, donor2	11582-120F7	103.13	2.77	2.08	1.38
Melanocyte - dark, donor3	11663-122F7	134.52	7.03	4.20	1.16
Melanocyte - light, donor1	11274-116H5	74.75	1.41	3.29	0.24
Melanocyte - light, donor2	11351-117H1	79.17	6.14	4.09	0.68
Melanocyte - light, donor3	11423-118G1	71.11	2.60	5.20	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	131.20	6.04	3.44	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	127.48	4.30	1.08	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	126.96	4.55	3.75	0.54
Meningeal Cells, donor1	11493-119E8	223.18	8.19	6.33	2.61
Meningeal Cells, donor2	11573-120E7	190.14	4.84	4.40	1.32
Meningeal Cells, donor3	11654-122E7	165.04	7.50	3.91	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	180.79	6.56	4.56	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	101.64	5.03	1.91	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	53.88	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	100.73	2.62	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	119.12	1.44	2.15	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	115.20	4.87	1.69	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	91.48	2.01	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	206.13	5.49	4.40	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	222.83	8.77	7.31	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	209.92	4.71	6.75	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	145.16	4.43	1.66	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	68.40	2.23	1.86	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	93.02	4.87	1.18	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	95.55	4.15	1.78	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	65.40	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	160.74	1.28	5.12	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	122.64	4.96	1.06	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	81.00	7.19	0.94	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	107.40	4.35	3.63	0.00
Mesothelial Cells, donor1	11247-116E5	112.17	1.33	1.86	0.00
Mesothelial Cells, donor2	12156-128G5	94.59	5.51	2.50	1.00
Mesothelial Cells, donor3	11402-118D7	94.96	1.52	2.89	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	27.83	0.74	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	25.03	1.47	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	28.52	0.31	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.16	0.83	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	24.03	1.25	1.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	21.88	0.93	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	21.74	0.81	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.84	1.58	1.58	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	24.32	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.71	0.64	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.90	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	18.07	1.51	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.01	0.95	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	10.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.89	0.46	0.69	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	21.66	0.84	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.79	0.61	0.41	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	19.31	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.56	1.11	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.52	0.44	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.65	0.51	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.04	0.00	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.88	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.74	0.96	1.44	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.61	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	29.53	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	26.71	0.44	3.07	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	13.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	28.76	0.74	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	15.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	29.74	0.68	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.82	0.44	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.78	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	36.47	0.84	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	21.61	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.74	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	27.15	1.81	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	28.80	1.67	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.01	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	23.90	1.14	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	18.38	0.41	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	24.88	0.26	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	24.45	0.86	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	19.75	1.07	1.33	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	31.13	1.20	0.90	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.66	0.42	0.57	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.30	1.27	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	28.75	1.33	1.33	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	19.04	0.85	1.14	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.46	1.23	1.97	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	16.29	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.76	1.18	1.18	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	34.89	0.29	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	17.72	0.41	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	20.25	1.49	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	31.87	1.64	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	15.78	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	32.42	1.38	0.99	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	34.46	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	37.55	0.75	1.13	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.30	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	23.75	0.68	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	20.63	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	28.21	0.73	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.83	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	20.20	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.60	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	9.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	9.79	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	12.55	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	113.75	6.03	3.45	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	74.21	2.61	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	196.91	2.67	4.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	90.15	1.67	6.68	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	193.56	5.13	6.27	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	110.11	3.19	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	114.91	0.68	2.72	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	64.32	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	138.53	3.35	4.19	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	207.10	2.79	6.04	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	142.68	1.89	5.67	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	94.61	1.05	3.99	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	158.34	3.47	6.45	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	106.91	2.71	3.52	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	133.29	2.72	3.85	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	134.72	0.82	2.61	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	76.91	0.55	0.73	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	125.18	1.59	2.12	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	116.46	4.20	3.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	96.81	1.31	4.27	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	103.27	1.95	2.93	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	59.09	1.41	1.76	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	104.78	2.11	4.22	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	118.60	2.30	3.68	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	124.36	1.61	4.18	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	96.57	2.07	4.48	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	0.00	5.06	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	57.48	0.45	1.34	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	84.68	1.69	1.69	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	104.67	1.42	1.42	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	132.21	1.72	4.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	138.95	1.67	3.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	39.23	1.35	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	89.68	1.59	3.97	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	91.01	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	102.54	2.65	3.78	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	82.77	1.96	3.58	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	86.29	0.00	2.61	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	42.51	0.90	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	98.77	0.88	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	123.00	0.00	3.32	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	111.61	0.50	4.96	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	94.94	0.77	2.68	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	71.07	2.42	2.42	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	56.58	0.88	2.21	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	77.25	2.71	4.74	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	112.18	1.22	3.05	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	77.74	0.94	2.52	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	92.01	1.82	3.93	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	75.16	0.79	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	62.35	0.00	5.67	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	126.22	4.60	3.48	0.50
Myoblast, donor2	11322-117D8	136.75	4.03	2.88	0.58
Myoblast, donor3	11398-118D3	128.81	4.37	2.52	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	154.25	5.55	4.96	1.46
Natural Killer Cells, donor1	11230-116C6	49.51	2.15	0.62	0.31
Natural Killer Cells, donor2	11311-117C6	47.04	1.21	0.60	0.00
Natural Killer Cells, donor3	11387-118C1	45.46	1.66	0.74	0.00
Neural stem cells, donor1	11275-116H6	139.37	5.08	5.44	1.45
Neural stem cells, donor2	11352-117H2	102.06	5.78	3.85	0.00
Neurons, donor1	11494-119E9	203.68	4.55	9.10	0.00
Neurons, donor2	11574-120E8	146.85	3.08	2.86	0.44
Neurons, donor3	11655-122E8	180.05	5.76	6.58	1.64
Neutrophils, donor1	11233-116C9	79.81	1.86	1.86	0.93
Neutrophils, donor2	11314-117C9	78.27	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	104.45	1.83	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	107.10	4.04	2.73	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	112.98	1.95	3.26	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	149.41	2.61	3.21	0.60
Olfactory epithelial cells, donor1	11933-125I7	78.46	2.75	2.34	0.28
Olfactory epithelial cells, donor2	11934-125I8	89.60	4.20	3.91	1.01
Olfactory epithelial cells, donor3	11935-125I9	73.55	1.48	2.27	0.34
Olfactory epithelial cells, donor4	11936-126A1	91.46	2.34	2.34	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	124.58	5.42	6.62	0.60
Osteoblast - differentiated, donor1	11276-116H7	166.11	3.62	2.77	0.64
Osteoblast - differentiated, donor2	11353-117H3	51.44	0.00	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	91.24	1.24	3.72	0.00
Osteoblast, donor1	11277-116H8	250.35	12.12	3.91	3.13
Osteoblast, donor2	11354-117H4	185.41	9.13	4.21	1.40
Osteoblast, donor3	11426-118G4	209.37	5.33	5.33	0.71
Pancreatic stromal cells, donor1	11249-116E7	182.45	6.32	4.97	1.52
Pericytes, donor1	11491-119E6	96.91	2.11	2.11	0.89
Pericytes, donor2	11571-120E5	101.64	0.91	2.72	0.23
Pericytes, donor3	11652-122E5	186.56	3.26	2.03	1.22
Perineurial Cells, donor1	11499-119F5	118.90	3.05	2.49	0.68
Perineurial Cells, donor2	11579-120F4	147.40	6.90	2.94	2.12
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	50.04	1.59	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	45.54	1.71	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	39.47	1.04	0.52	0.13
Placental Epithelial Cells, donor1	11278-116H9	54.77	2.15	2.39	0.72
Placental Epithelial Cells, donor2	11355-117H5	65.42	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	71.46	3.93	2.16	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	73.73	2.53	2.22	0.32
Preadipocyte - breast, donor1	11467-119B9	89.67	4.31	1.69	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	39.81	3.26	1.17	0.26
Preadipocyte - breast, donor2	11328-117E5	77.68	3.15	2.03	0.45
Preadipocyte - omental, donor1	11468-119C1	84.07	4.69	1.92	0.32
Preadipocyte - omental, donor2	11329-117E6	96.90	2.62	2.62	0.00
Preadipocyte - omental, donor3	11403-118D8	82.08	3.44	2.29	0.29
Preadipocyte - perirenal, donor1	11469-119C2	96.46	3.94	3.94	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	173.21	5.84	3.69	2.15
Preadipocyte - subcutaneous, donor2	11356-117H6	159.55	3.90	3.54	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	144.06	5.96	1.70	1.53
Preadipocyte - visceral, donor1	11280-116I2	193.09	6.71	4.84	1.12
Preadipocyte - visceral, donor2	11357-117H7	164.28	6.90	2.30	0.46
Preadipocyte - visceral, donor3	11429-118G7	139.49	3.97	4.28	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	142.71	4.98	6.64	2.26
Prostate Epithelial Cells, donor2	11331-117E8	100.21	3.25	3.11	1.35
Prostate Epithelial Cells, donor3	11404-118D9	92.77	2.33	2.02	0.37
Prostate Stromal Cells, donor1	11254-116F3	163.22	5.81	4.33	1.14
Prostate Stromal Cells, donor2	11332-117E9	158.86	4.84	4.84	1.26
Prostate Stromal Cells, donor3	11405-118E1	120.54	3.96	2.92	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	118.98	5.84	2.55	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	86.92	4.92	1.87	1.04
Renal Epithelial Cells, donor1	11517-119H5	90.79	1.01	3.55	0.00
Renal Epithelial Cells, donor2	11597-120H4	114.52	3.56	7.11	0.00
Renal Epithelial Cells, donor3	11678-122H4	96.13	4.98	1.80	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	121.87	2.72	4.09	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	158.48	2.29	4.45	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	109.90	2.44	2.66	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	54.57	0.00	1.33	1.33
Renal Mesangial Cells, donor1	11518-119H6	167.71	3.52	5.50	0.66
Renal Mesangial Cells, donor2	11598-120H5	111.60	3.13	3.13	0.63
Renal Mesangial Cells, donor3	11679-122H5	81.84	2.50	1.66	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	158.91	5.64	5.37	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	101.21	5.06	2.95	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	138.46	3.28	4.82	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	155.83	5.19	2.85	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	121.09	2.56	3.98	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	126.58	2.06	7.20	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	74.27	1.76	1.76	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	88.47	1.47	2.00	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	108.10	5.36	4.47	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	159.06	8.26	2.75	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	93.39	5.80	2.90	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	137.05	4.16	6.11	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	154.82	3.38	6.55	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	194.75	7.36	6.58	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	196.98	4.96	6.33	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	164.44	3.38	4.55	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	188.60	4.62	5.78	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	129.10	3.01	6.43	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	161.71	2.87	6.05	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	169.69	3.40	5.91	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	148.91	3.59	4.73	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	160.22	3.97	6.12	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	191.84	2.66	7.30	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	121.01	3.44	6.88	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	158.10	3.07	6.24	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	185.09	6.20	8.08	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	145.05	2.39	6.24	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	137.06	2.82	4.38	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	186.57	5.54	7.64	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	149.51	2.88	6.09	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	146.88	5.05	4.77	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	142.02	3.76	6.67	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	140.76	3.28	6.56	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	147.40	4.66	4.66	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	172.47	3.63	6.58	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	153.32	3.54	7.78	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	163.10	4.17	6.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	181.93	4.44	7.48	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	159.66	3.11	5.60	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	145.56	5.97	5.53	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	161.68	2.09	7.94	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	154.91	2.29	6.59	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	150.37	3.41	6.47	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	181.61	3.86	7.52	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	152.85	2.06	6.88	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	161.17	3.70	6.86	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	181.41	3.28	6.57	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	137.71	2.22	5.45	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	148.99	4.59	5.62	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	141.80	2.93	5.86	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	122.37	3.18	2.90	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	168.58	4.52	6.43	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	167.28	4.03	5.44	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	139.75	4.71	3.39	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	128.22	3.49	3.49	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	101.85	3.32	3.93	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	148.70	4.41	2.57	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	146.57	9.90	3.64	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	138.11	5.48	2.43	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	154.92	4.82	2.11	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	121.69	5.65	2.71	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	124.91	5.09	3.89	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	110.75	4.60	2.95	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	134.26	5.76	2.56	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	129.21	5.41	3.00	0.60
Schwann Cells, donor1	11498-119F4	175.66	2.63	3.20	0.38
Schwann Cells, donor2	11578-120F3	142.90	6.80	3.40	0.00
Schwann Cells, donor3	11659-122F3	123.34	2.63	5.04	0.22
Sebocyte, donor1	11220-116B5	159.95	8.76	3.29	0.55
Sebocyte, donor2	11301-117B5	116.27	1.84	2.30	1.84
Sebocyte, donor3	11378-118B1	93.37	3.09	2.27	1.24
Sertoli Cells, donor1	11255-116F4	152.41	4.97	3.31	0.00
Sertoli Cells, donor2	11333-117F1	90.38	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	157.66	3.43	2.20	0.62
Skeletal Muscle Cells, donor2	11358-117H8	62.89	0.72	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	226.57	6.69	4.18	1.67
Skeletal Muscle Cells, donor4	11451-119A2	131.49	2.04	4.08	0.47
Skeletal Muscle Cells, donor5	11455-119A6	116.54	2.82	4.01	1.34
Skeletal Muscle Cells, donor6	11459-119B1	138.20	3.54	4.46	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	150.07	5.67	3.53	1.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	128.13	4.00	2.71	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	161.51	4.66	3.57	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	111.30	2.95	2.95	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	146.20	4.34	2.17	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	148.61	3.16	2.89	1.65
Skin - palm, donor1	10286-104F7	10.74	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	105.81	2.45	4.32	1.15
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	89.97	6.54	7.36	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	113.21	3.89	3.64	1.82
Small Airway Epithelial Cells, donor1	11256-116F5	111.90	4.87	4.17	1.53
Small Airway Epithelial Cells, donor2	11334-117F2	82.28	2.11	1.69	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	74.85	6.98	2.75	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	73.30	1.72	1.57	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	201.51	2.78	3.39	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	46.02	2.89	2.22	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	161.65	3.53	3.53	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	134.14	3.76	5.52	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	187.83	7.09	4.73	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	177.69	3.86	3.09	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	101.08	3.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	170.74	5.99	3.46	1.46
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	112.16	2.22	2.22	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	182.83	5.25	5.51	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	108.42	2.93	2.28	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	114.59	3.54	2.66	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	94.53	1.71	3.56	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	148.68	2.77	3.58	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	102.29	2.74	2.74	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	189.93	7.83	3.54	2.53
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	0.00	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	134.47	5.72	4.29	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	88.04	2.51	2.06	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	88.25	1.72	3.23	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	110.73	2.94	2.94	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	221.19	8.20	7.58	1.86
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	160.60	4.31	6.47	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	153.91	3.59	2.69	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	135.88	4.10	3.76	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	123.92	4.00	1.73	1.73
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	161.83	7.65	3.82	1.51
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	99.90	3.64	2.05	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	166.65	6.04	2.42	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	162.66	6.09	6.09	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	143.15	6.26	5.06	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	143.13	3.51	4.01	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	76.61	1.78	1.27	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	278.18	12.97	5.58	2.56
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	153.78	5.25	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	534.98	1.29	52.98	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	203.24	6.98	4.65	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	142.38	4.54	4.04	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	98.72	4.07	3.76	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	128.03	2.65	5.01	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	176.53	6.58	5.75	1.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	108.38	1.87	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	201.20	7.05	4.32	1.44
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	207.53	4.59	2.80	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	232.60	6.39	6.21	2.63
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	168.67	5.59	3.91	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	138.75	4.27	3.35	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	39.52	0.95	1.90	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	190.59	6.61	4.16	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	185.60	5.08	3.98	2.21
Smooth Muscle Cells - Uterine, donor3	11466-119B8	141.61	5.56	4.10	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	65.69	2.14	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	70.61	1.32	2.12	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	85.92	4.84	3.72	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	94.51	2.16	2.52	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	79.49	1.42	2.84	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	103.98	3.94	3.15	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	86.09	4.32	2.03	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	80.66	1.60	1.60	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	67.30	2.09	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	82.96	0.92	2.29	0.00
Synoviocyte, donor1	11291-117A4	90.22	5.22	2.52	1.18
Synoviocyte, donor2	11368-117I9	71.91	3.69	0.84	0.34
Synoviocyte, donor3	11440-118H9	78.19	1.56	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	233.34	2.50	3.57	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	59.46	5.95	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	118.09	4.40	3.01	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	121.65	5.95	3.44	1.51
Tracheal Epithelial Cells, donor2	11369-118A1	105.15	4.25	3.09	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	95.63	2.86	2.86	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	87.47	2.95	1.97	0.25
Urethra, donor2	10319-105A4	53.95	0.00	3.60	0.00
Urothelial Cells, donor1	11520-119H8	127.25	3.19	2.66	0.80
Urothelial Cells, donor2	11600-120H7	100.54	4.41	0.80	0.80
Urothelial Cells, donor3	11681-122H7	97.87	3.90	1.38	0.92
Urothelial cells, donor0	11216-116B1	108.10	6.46	1.78	2.23
Whole blood (ribopure), donor090309, donation1	12179-129A1	80.08	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	72.91	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	53.39	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	54.06	1.03	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	48.81	1.16	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	68.72	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	60.57	0.92	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	46.56	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	84.87	3.08	2.71	0.86
Wilms' tumor cell line:HFWT	10597-108E3	39.60	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	104.46	6.70	5.03	0.28
achilles tendon, donor2	10292-104G4	45.46	0.00	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	166.49	3.57	3.82	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	68.03	1.39	3.48	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	71.94	0.71	4.51	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	68.03	1.36	2.18	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	89.10	2.53	3.94	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	70.42	3.81	1.90	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	72.68	0.82	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	49.79	1.76	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	71.05	1.23	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	83.48	2.72	2.72	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	37.72	0.55	1.47	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	94.11	2.09	2.79	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	61.10	0.78	1.55	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	49.68	2.63	2.34	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	62.28	1.39	2.79	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	91.71	2.47	3.70	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	109.27	0.61	7.98	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	120.76	1.71	7.68	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	107.06	2.43	4.55	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	115.30	2.89	3.61	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	72.17	3.12	3.79	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	40.69	4.00	1.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	52.36	1.13	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.97	0.87	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	142.48	5.65	0.94	2.12
adipose tissue, adult, pool1	10010-101C1	66.70	1.55	0.62	0.31
adipose, donor1	10184-103D4	114.94	6.45	7.62	2.93
adipose, donor2	10185-103D5	79.08	0.41	6.89	0.41
adipose, donor3	10186-103D6	74.88	2.45	5.45	1.09
adipose, donor4	10187-103D7	76.27	3.47	20.80	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	201.06	2.53	10.42	0.47
adrenal gland, adult, pool1	10081-102A9	76.39	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	66.04	3.87	2.00	1.87
alveolar cell carcinoma cell line:SW 1573	10708-109H6	269.76	5.36	7.15	0.71
amniotic membrane cells, donor1	12235-129G3	45.44	0.93	1.39	0.23
amniotic membrane cells, donor2	12236-129G4	65.59	2.03	2.37	0.00
amniotic membrane cells, donor3	12237-129G5	33.29	2.06	0.88	0.29
amygdala - adult, donor10196	10167-103B5	118.58	13.04	7.11	4.74
amygdala, adult, donor10252	10151-102I7	101.38	4.26	2.64	0.81
amygdala, newborn, donor10223	10360-105E9	73.59	1.94	4.52	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	104.16	4.97	1.53	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	107.44	2.87	3.31	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	121.26	5.01	1.34	0.33
aorta, adult, pool1	10052-101G7	83.36	1.77	0.78	0.78
appendix, adult	10189-103D9	86.16	0.78	1.94	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	184.01	8.94	4.82	0.34
artery, adult	10190-103E1	58.42	1.36	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	116.62	3.33	2.61	1.01
b cell line:RPMI1788	10427-106D4	43.27	1.64	0.59	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	123.19	3.61	1.66	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	115.90	4.76	2.38	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	88.71	3.68	0.33	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	31.88	1.12	0.56	0.00
bladder, adult, pool1	10011-101C2	56.17	1.52	1.09	0.33
blood, adult, pool1	10053-101G8	50.94	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	47.10	5.99	0.86	0.00
bone marrow, adult	10192-103E3	72.88	2.02	2.02	0.00
brain, adult, donor1	10084-102B3	114.81	3.08	3.08	1.03
brain, adult, pool1	10012-101C3	97.33	6.01	2.45	1.34
brain, fetal, pool1	10085-102B4	165.63	5.34	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	91.51	2.31	4.63	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	31.95	1.12	0.75	0.37
breast, adult, donor1	10080-102A8	98.49	0.63	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	244.93	3.18	6.48	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	88.44	3.71	4.33	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	213.64	4.37	6.22	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	137.75	3.15	4.12	1.21
carcinoid cell line:NCI-H1770	10703-109H1	237.43	4.70	6.11	0.00
carcinoid cell line:NCI-H727	10735-110B6	87.18	1.64	2.52	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	141.65	1.90	2.54	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	162.10	3.46	2.93	1.86
caudate nucleus - adult, donor10196	10177-103C6	102.47	0.00	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	99.39	3.85	2.68	0.33
caudate nucleus, adult, donor10258	10379-105H1	84.06	7.64	6.88	0.00
caudate nucleus, newborn, donor10223	10354-105E3	91.56	1.83	4.39	0.73
cerebellum - adult, donor10196	10173-103C2	148.58	8.74	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	115.51	3.42	3.42	0.64
cerebellum, adult, pool1	10083-102B2	102.79	4.48	5.17	1.03
cerebellum, newborn, donor10223	10357-105E6	102.13	3.32	9.13	0.83
cerebral meninges, adult	10188-103D8	86.99	3.53	1.01	2.02
cerebrospinal fluid, donor2	10294-104G6	37.28	0.73	4.39	0.73
cervical cancer cell line:D98-AH2	10552-107I3	92.02	2.73	2.30	0.43
cervical cancer cell line:ME-180	10553-107I4	91.14	5.97	1.33	1.16
cervix, adult, pool1	10013-101C4	91.76	3.78	2.10	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	83.46	3.76	1.67	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	58.78	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	142.54	4.97	6.21	1.24
choriocarcinoma cell line:SCH	10785-110H2	166.46	3.20	7.27	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	86.10	0.95	2.37	0.24
chorionic membrane cells, donor1	12238-129G6	53.56	2.28	0.85	0.28
chorionic membrane cells, donor2	12239-129G7	86.80	4.08	2.59	0.99
chorionic membrane cells, donor3	12240-129G8	69.24	2.20	2.20	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	46.45	1.01	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	55.13	1.92	2.88	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	58.29	1.69	2.11	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	50.59	4.88	4.88	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	65.55	4.60	2.18	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	65.97	5.09	2.85	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	66.25	2.36	4.71	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	53.95	3.13	1.30	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	77.26	6.17	2.06	1.14
clear cell carcinoma cell line:TEN	10636-108I6	141.23	3.82	5.21	0.87
colon carcinoma cell line:CACO-2	10513-107D9	157.97	3.66	6.96	1.28
colon carcinoma cell line:COLO-320	10420-106C6	304.83	29.27	8.74	11.02
colon, adult, donor1	10082-102B1	111.86	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	122.32	6.35	1.76	1.29
colon, fetal, donor1	10070-101I7	88.99	2.47	3.09	1.24
common myeloid progenitor CMP, donor1	12130-128D6	32.08	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	62.04	5.52	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	44.52	3.32	0.60	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	48.65	3.95	1.69	1.13
corpus callosum, adult, pool1	10042-101F6	114.10	5.53	2.99	0.55
cruciate ligament, donor2	10295-104G7	63.22	1.62	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	70.63	0.80	3.21	0.80
diencephalon, adult	10193-103E4	99.12	3.12	3.36	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	97.58	1.84	4.36	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	100.27	2.56	2.05	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	235.43	15.89	5.78	1.69
ductus deferens, adult	10196-103E7	106.15	1.99	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	106.58	1.44	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	109.61	5.89	2.21	0.00
dura mater, adult, donor1	10041-101F5	84.65	5.04	1.24	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	80.61	12.44	2.66	2.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	167.80	5.30	9.17	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	56.73	1.23	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	86.58	4.24	2.42	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	78.11	1.23	2.78	0.62
embryonic pancreas cell line:2C6	10603-108E9	68.30	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	145.81	0.34	7.37	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	161.12	1.63	4.17	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	120.77	4.82	2.73	0.96
epidermoid carcinoma cell line:A431	10426-106D3	114.38	11.67	2.11	3.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	213.59	10.12	5.72	1.43
epididymis, adult	10197-103E8	76.82	2.51	1.26	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	120.99	2.48	1.60	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	98.70	2.75	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	120.83	2.88	3.80	1.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	101.18	4.04	3.35	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	123.68	4.15	3.81	1.34
esophagus, adult, pool1	10015-101C6	81.86	4.25	1.70	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	78.77	1.75	2.38	0.13
eye - muscle inferior rectus, donor1	10272-104E2	55.54	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	33.67	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	31.25	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	48.15	2.29	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	45.18	1.46	5.83	0.00
eye, fetal, donor1	10054-101G9	75.00	1.27	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	163.49	10.00	3.08	1.80
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	141.03	2.37	5.70	0.47
frontal lobe, adult, pool1	10040-101F4	128.63	8.91	3.10	1.78
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	120.10	1.80	4.50	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	190.19	7.31	4.11	1.10
gall bladder, adult	10198-103E9	80.40	3.38	2.17	1.45
gamma delta positive T cells, donor1	11937-126A2	44.56	1.61	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	47.43	0.75	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	37.81	3.17	2.11	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	111.60	4.26	3.67	0.77
gastric cancer cell line:AZ521	10549-107H9	134.28	4.59	5.41	0.98
gastric cancer cell line:GSS	10560-108A2	53.08	0.92	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	58.48	4.80	2.06	1.60
giant cell carcinoma cell line:LU65	10487-107B1	127.36	3.44	4.13	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	48.85	2.10	1.26	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	81.06	1.50	2.24	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	140.70	3.91	3.69	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	153.64	3.51	4.07	0.28
glioblastoma cell line:T98G	10485-107A8	143.49	6.18	3.64	0.66
glioma cell line:GI-1	10413-106B8	172.50	6.15	4.98	1.46
globus pallidus - adult, donor10196	10175-103C4	101.32	2.92	3.64	1.46
globus pallidus, adult, donor10252	10161-103A8	98.37	2.20	1.95	0.00
globus pallidus, adult, donor10258	10367-105F7	78.04	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	56.49	0.00	4.26	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	36.71	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	47.36	4.16	1.28	0.64
hIPS +CCl2, biol_rep1	14383-156B9	76.21	3.67	7.80	0.46
hIPS +CCl2, biol_rep2	14384-156C1	81.39	3.20	4.57	0.00
hIPS +CCl2, biol_rep3	14385-156C2	71.49	6.44	5.80	0.00
hIPS, biol_rep1	14380-156B6	27.31	0.00	5.75	0.00
hIPS, biol_rep2	14381-156B7	45.95	2.74	9.60	0.69
hIPS, biol_rep3	14382-156B8	83.86	5.52	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	27.87	2.59	0.86	0.29
heart - mitral valve, adult	10205-103F7	65.47	1.49	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	86.55	4.18	1.57	0.52
heart - tricuspid valve, adult	10207-103F9	83.26	1.67	3.33	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	117.33	2.86	4.69	1.22
heart, adult, diseased, donor1	10051-101G6	87.72	2.55	0.85	2.55
heart, adult, pool1	10016-101C7	82.33	4.37	2.07	0.69
heart, fetal, pool1	10046-101G1	111.00	5.34	1.85	2.36
hepatic mesenchymal tumor cell line:LI90	10778-110G4	96.88	3.09	2.16	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	42.81	0.00	5.95	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	86.52	4.97	1.77	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	96.74	6.31	2.79	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	91.55	4.65	3.44	1.31
hepatoma cell line:Li-7	10484-107A7	134.24	4.45	3.00	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	55.88	3.72	3.02	0.70
hippocampus - adult, donor10196	10169-103B7	160.88	16.09	6.62	0.00
hippocampus, adult, donor10252	10153-102I9	105.72	2.86	2.04	1.43
hippocampus, adult, donor10258	10374-105G5	75.69	4.98	2.99	1.49
hippocampus, newborn, donor10223	10363-105F3	112.44	7.75	8.11	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	125.12	10.38	4.88	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	99.36	4.32	4.12	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	116.28	4.06	2.54	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	123.49	2.26	3.38	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	154.93	4.65	4.13	2.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	178.80	4.18	3.04	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	104.52	3.80	5.26	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	127.75	3.45	3.23	1.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	106.77	4.59	3.34	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	115.55	3.79	3.55	2.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	118.61	6.59	4.02	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	125.91	6.06	8.08	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	107.50	3.29	3.13	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	91.38	3.93	3.44	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	141.39	7.85	3.49	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	147.96	5.54	5.15	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	136.49	3.92	6.11	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	111.95	8.00	5.00	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	104.56	2.64	4.71	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	117.77	3.64	3.64	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	95.85	3.13	3.76	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	88.51	4.25	3.43	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	86.22	3.19	2.03	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	77.12	3.29	3.29	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	106.78	3.88	3.51	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	117.54	5.42	3.42	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	122.49	4.49	4.49	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	134.85	5.28	5.28	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	121.95	2.22	4.43	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	114.09	2.72	2.72	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	113.77	4.14	5.17	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	114.90	2.66	1.99	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	86.96	2.05	4.62	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	97.66	2.56	3.07	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	114.34	9.09	2.27	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	102.50	5.71	2.35	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	100.71	1.45	3.62	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	102.50	5.35	7.58	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	92.68	3.90	3.41	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	140.28	2.14	1.83	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	299.30	13.01	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	148.92	7.28	3.97	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	110.01	4.93	9.30	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	102.41	2.17	3.26	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	98.93	3.56	4.63	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	89.50	1.19	3.58	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	117.28	5.55	3.25	2.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	77.86	4.31	4.31	1.35
immature langerhans cells, donor1	11904-125F5	20.10	1.21	0.48	0.48
immature langerhans cells, donor2	11905-125F6	26.14	1.58	0.79	0.00
insula, adult, pool1	10039-101F3	144.60	9.27	3.69	2.46
keratoacanthoma cell line:HKA-1	10791-110H8	114.45	3.90	3.58	1.30
kidney, adult, pool1	10017-101C8	77.60	2.90	2.60	0.40
kidney, fetal, pool1	10045-101F9	82.48	2.90	2.55	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	219.14	5.54	7.39	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	131.61	10.78	1.52	1.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	27.34	1.10	1.10	0.18
left atrium, adult, donor1	10079-102A7	65.93	3.27	1.09	0.54
left ventricle, adult, donor1	10078-102A6	79.39	3.03	2.02	1.01
leiomyoblastoma cell line:G-402	10721-110A1	78.53	1.09	2.74	0.00
leiomyoma cell line:10964C	10569-108B2	156.27	5.03	6.47	1.80
leiomyoma cell line:15242A	10570-108B3	117.39	4.35	5.98	0.54
leiomyoma cell line:15425	10571-108B4	175.31	6.80	6.07	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	93.05	0.00	4.18	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	39.08	2.24	1.42	1.06
liposarcoma cell line:KMLS-1	10782-110G8	106.38	1.72	1.87	0.78
liposarcoma cell line:SW 872	10726-110A6	131.46	6.34	4.26	0.97
liver, adult, pool1	10018-101C9	82.33	2.27	1.30	0.81
liver, fetal, pool1	10086-102B5	61.15	0.94	3.76	0.00
locus coeruleus - adult, donor10196	10182-103D2	101.93	3.79	5.25	0.58
locus coeruleus, adult, donor10252	10165-103B3	96.70	3.14	3.14	0.18
locus coeruleus, adult, donor10258	10375-105G6	113.42	11.29	2.82	0.56
locus coeruleus, newborn, donor10223	10362-105F2	103.47	5.89	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	73.63	1.80	1.52	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	93.76	3.45	2.07	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	245.57	6.59	5.93	1.85
lung, adult, pool1	10019-101D1	66.27	1.30	1.06	0.12
lung, fetal, donor1	10068-101I5	87.05	1.71	2.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	85.69	0.92	1.37	0.92
lymph node, adult, donor1	10077-102A5	66.27	2.37	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	48.22	0.66	1.10	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	983.44	18.87	45.43	3.92
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	71.36	2.55	1.70	0.85
mature adipocyte, donor1	12231-129F8	43.95	1.33	1.33	0.89
mature adipocyte, donor2	12232-129F9	53.54	1.66	1.45	0.21
mature adipocyte, donor3	12233-129G1	80.60	1.42	1.66	0.24
mature adipocyte, donor4	12234-129G2	63.17	1.05	2.37	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	84.11	2.14	2.38	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	139.88	3.38	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	113.65	4.41	3.86	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	83.55	3.18	2.86	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	72.50	7.68	1.71	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	120.15	6.58	2.19	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	104.20	2.97	2.33	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	80.90	3.85	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	71.79	3.95	2.87	1.44
medulla oblongata - adult, donor10196	10174-103C3	88.26	4.54	3.24	0.65
medulla oblongata, adult, donor10252	10155-103A2	84.37	2.63	2.17	0.62
medulla oblongata, adult, pool1	10038-101F2	100.32	5.96	3.92	1.31
medulla oblongata, newborn, donor10223	10361-105F1	66.31	2.08	4.17	0.35
medulloblastoma cell line:D283 Med	10838-111E1	44.06	0.89	1.11	0.44
medulloblastoma cell line:ONS-76	10759-110E3	174.61	7.95	7.58	1.47
melanoma cell line:COLO 679	10514-107E1	104.22	4.17	1.44	0.72
melanoma cell line:G-361	10465-106H6	207.13	14.12	2.17	2.71
meningioma cell line:HKBMM	10691-109F7	70.91	3.26	1.09	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	215.00	7.05	8.81	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	172.38	3.37	3.63	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	164.48	5.52	3.53	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	103.43	3.27	2.18	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	154.46	2.48	2.07	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	151.85	2.67	1.97	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	91.08	1.16	1.93	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	85.37	2.08	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	92.00	2.57	1.20	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	120.54	2.99	2.65	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	136.75	4.11	2.39	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	138.82	3.24	3.24	1.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	128.32	3.84	2.85	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	94.20	1.32	2.31	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	132.15	3.18	2.49	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	181.87	5.93	3.14	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	134.34	3.67	2.86	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	78.36	2.88	2.88	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	106.14	2.48	2.17	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	83.22	0.91	1.60	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	179.15	6.71	6.71	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	110.58	2.84	2.39	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	142.59	2.80	2.80	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	117.07	2.58	3.31	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	90.43	1.72	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	130.09	3.37	3.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	110.97	3.65	2.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	117.41	3.07	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	117.79	2.62	3.93	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	110.30	0.62	2.77	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	100.26	1.65	2.12	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	114.74	1.69	4.74	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	103.35	2.36	3.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	106.12	4.17	2.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	144.21	4.90	2.88	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	124.94	3.12	3.57	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	119.70	2.40	3.85	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	83.60	1.47	2.93	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	112.78	1.68	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	116.26	2.46	3.68	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	112.54	1.72	3.01	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	147.66	2.73	8.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	77.47	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	122.44	2.27	2.92	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	110.58	1.45	2.91	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	144.46	2.67	3.20	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	97.31	3.27	3.27	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	120.50	1.94	3.11	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	113.33	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	102.33	1.99	2.98	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	100.11	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	119.19	2.37	5.34	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	120.63	2.44	4.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	116.54	0.63	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	92.09	2.07	3.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	88.12	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	63.87	0.00	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	68.88	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	72.94	1.22	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	55.61	1.59	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	50.70	0.59	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	61.41	1.25	0.94	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	49.46	1.34	2.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	73.33	2.37	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	56.50	2.57	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	58.51	1.38	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	79.17	0.49	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	72.90	1.12	3.36	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	72.51	0.64	2.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	81.81	2.42	4.03	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	87.22	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	65.89	2.53	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	62.51	3.03	1.82	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	72.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	62.60	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	56.15	0.99	1.19	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	65.55	1.30	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	42.78	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	25.53	2.32	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	132.30	1.89	4.72	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	111.44	6.26	3.48	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	128.21	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	153.61	10.58	2.98	1.95
mesothelioma cell line:Mero-25	10850-111F4	41.31	2.50	2.04	0.23
mesothelioma cell line:Mero-41	10851-111F5	151.57	5.87	4.89	1.71
mesothelioma cell line:Mero-48a	10852-111F6	173.16	6.64	5.31	1.33
mesothelioma cell line:Mero-82	10853-111F7	80.16	5.26	2.63	1.58
mesothelioma cell line:Mero-83	10854-111F8	87.15	4.09	1.87	0.68
mesothelioma cell line:Mero-84	10855-111F9	119.81	3.54	3.03	0.51
mesothelioma cell line:Mero-95	10856-111G1	98.35	5.59	2.07	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	95.41	3.15	2.65	0.99
mesothelioma cell line:NCI-H226	10846-111E9	157.82	5.25	1.99	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	148.27	4.78	5.12	1.37
mesothelioma cell line:NCI-H28	10845-111E8	92.88	1.78	8.91	0.25
mesothelioma cell line:No36	10857-111G2	75.35	1.30	1.63	0.33
mesothelioma cell line:ONE58	10858-111G3	92.39	2.71	2.44	1.08
migratory langerhans cells, donor1	11901-125F2	27.06	0.00	0.77	0.19
migratory langerhans cells, donor2	11902-125F3	30.04	0.24	0.98	0.12
migratory langerhans cells, donor3	11903-125F4	36.43	1.26	0.72	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	111.00	3.59	2.94	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	79.05	3.81	3.39	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	233.12	8.06	8.06	2.07
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	36.73	1.14	0.76	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	49.34	2.03	2.22	0.74
myeloma cell line:PCM6	10474-106I6	112.47	5.93	0.99	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	62.90	4.06	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	228.89	8.43	2.16	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	71.42	1.89	1.11	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	65.60	2.35	1.54	0.66
nasal epithelial cells, donor2	12227-129F4	119.23	4.42	7.73	1.66
neuroblastoma cell line:CHP-134	10508-107D4	108.82	4.60	2.99	0.00
neuroblastoma cell line:NB-1	10539-107G8	165.94	5.80	5.05	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	103.97	2.95	2.32	0.42
neuroblastoma cell line:NH-12	10555-107I6	85.72	3.17	2.61	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	143.28	2.85	2.85	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	107.86	2.22	3.17	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	161.61	2.21	4.03	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	90.28	0.00	4.45	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	121.64	3.19	4.79	1.06
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	132.08	4.90	6.43	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	222.54	8.81	7.20	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	102.91	4.81	2.56	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	82.77	2.63	1.84	1.05
nucleus accumbens, adult, pool1	10037-101F1	129.27	6.47	3.09	0.37
occipital cortex - adult, donor10196	10172-103C1	164.83	10.30	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	110.03	3.22	3.22	1.34
occipital cortex, newborn, donor10223	10355-105E4	86.62	2.91	2.55	1.46
occipital lobe, adult, donor1	10076-102A4	131.20	7.61	4.72	1.31
occipital lobe, fetal, donor1	10073-102A1	210.69	3.43	8.15	1.29
occipital pole, adult, pool1	10036-101E9	127.72	7.02	3.00	1.42
olfactory region, adult	10195-103E6	102.21	5.92	1.72	1.34
optic nerve, donor1	10277-104E7	74.04	4.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	111.17	5.01	2.85	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	140.96	5.63	4.95	1.65
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	73.15	2.03	1.86	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	178.11	4.74	4.16	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	68.79	2.65	1.47	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	53.26	5.61	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	85.88	2.76	3.39	0.42
ovary, adult, pool1	10020-101D2	71.28	2.45	1.31	1.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	150.69	3.30	3.67	0.55
pancreas, adult, donor1	10049-101G4	102.53	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	154.58	2.80	7.27	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	101.36	3.58	2.21	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	745.29	35.93	14.74	12.09
paracentral gyrus, adult, pool1	10035-101E8	132.07	5.22	3.20	0.92
parietal cortex, adult, donor10258	10373-105G4	87.35	5.87	6.61	0.73
parietal lobe - adult, donor10196	10171-103B9	95.93	3.76	4.70	0.94
parietal lobe, adult, donor10252	10157-103A4	94.35	2.57	2.57	0.57
parietal lobe, adult, pool1	10034-101E7	135.00	7.75	3.70	1.41
parietal lobe, fetal, donor1	10072-101I9	192.03	0.00	6.79	0.00
parietal lobe, newborn, donor10223	10356-105E5	83.37	5.61	4.11	1.12
parotid gland, adult	10199-103F1	75.23	1.85	2.47	0.00
penis, adult	10200-103F2	69.29	3.76	1.07	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	114.16	3.16	1.30	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	191.01	5.10	6.41	0.87
pineal gland - adult, donor10196	10179-103C8	107.72	6.45	1.94	1.94
pineal gland, adult, donor10252	10160-103A7	161.67	6.51	2.37	2.37
pineal gland, adult, donor10258	10377-105G8	89.67	9.41	4.39	1.88
pituitary gland - adult, donor10196	10180-103C9	98.14	9.11	3.04	2.02
pituitary gland, adult, donor10252	10162-103A9	153.75	4.69	5.21	0.52
pituitary gland, adult, donor10258	10378-105G9	103.00	3.40	4.26	1.70
placenta, adult, pool1	10021-101D3	74.93	2.26	2.80	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	56.41	2.65	1.85	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	79.53	1.25	2.80	0.47
pons, adult, pool1	10033-101E6	109.22	7.06	3.70	1.12
postcentral gyrus, adult, pool1	10032-101E5	128.15	5.84	3.49	1.92
promyelocytes/myelocytes PMC, donor1	12132-128D8	25.10	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	155.57	3.64	4.81	0.15
prostate cancer cell line:PC-3	10439-106E7	333.60	8.35	7.80	2.00
prostate, adult, pool1	10022-101D4	74.00	1.54	1.09	0.45
putamen, adult, donor10196	10176-103C5	136.21	4.96	2.36	1.18
putamen, adult, donor10252	10152-102I8	82.35	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	52.45	3.28	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	85.53	1.69	2.17	1.21
putamen, newborn, donor10223	10365-105F5	119.95	2.25	4.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	74.77	3.49	3.20	1.16
rectum, fetal, donor1	10067-101I4	132.14	5.56	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	135.04	1.06	5.51	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	140.00	1.24	2.07	0.83
retina, adult, pool1	10030-101E3	110.83	4.27	1.79	0.80
retinoblastoma cell line:Y79	10475-106I7	159.52	6.75	4.42	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	127.13	2.34	3.07	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	144.54	1.69	4.22	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	74.27	0.76	2.27	0.00
salivary acinar cells, donor1	11771-123I7	102.78	3.72	0.32	0.81
salivary acinar cells, donor2	11772-123I8	107.95	2.62	1.10	0.55
salivary acinar cells, donor3	11773-123I9	50.98	2.65	0.00	0.66
salivary gland, adult, pool1	10093-102C3	63.49	2.29	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	149.82	10.12	3.88	2.61
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	156.58	9.05	3.17	1.88
seminal vesicle, adult	10201-103F3	101.58	2.65	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	36.20	0.73	1.21	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	53.60	2.26	1.01	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	108.38	2.01	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	151.11	5.64	3.90	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	111.08	6.41	2.76	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	133.28	5.81	3.87	1.29
skeletal muscle - soleus muscle, donor1	10282-104F3	16.31	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	44.38	1.68	0.72	0.36
skeletal muscle, fetal, donor1	10066-101I3	61.31	1.01	3.02	0.00
skin, adult, donor1	10074-102A2	122.13	0.00	13.57	0.00
skin, fetal, donor1	10065-101I2	103.52	1.89	1.89	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	183.77	2.67	7.34	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	104.02	5.04	1.89	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	134.54	2.51	7.32	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	154.77	5.93	4.78	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	98.76	2.41	6.11	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	132.71	9.81	2.83	1.31
small intestine, adult, pool1	10024-101D6	173.79	7.88	3.11	1.79
small intestine, fetal, donor1	10064-101I1	159.70	6.39	3.69	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	300.56	10.26	7.69	2.05
smooth muscle, adult, pool1	10048-101G3	64.10	2.58	1.55	0.00
somatostatinoma cell line:QGP-1	10781-110G7	102.92	2.41	2.95	0.00
spinal cord - adult, donor10196	10181-103D1	87.86	2.29	2.98	0.69
spinal cord, adult, donor10252	10159-103A6	61.90	2.37	1.58	0.00
spinal cord, adult, donor10258	10369-105F9	71.26	2.08	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	111.60	6.10	2.44	1.22
spinal cord, newborn, donor10223	10359-105E8	56.02	2.76	3.21	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	129.04	2.84	2.84	0.15
spleen, adult, pool1	10025-101D7	64.21	2.86	0.88	0.44
spleen, fetal, pool1	10044-101F8	68.81	1.91	1.11	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	78.57	4.24	1.66	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	168.61	5.13	5.13	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	140.48	4.19	6.29	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	325.65	14.07	8.99	3.52
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	579.23	51.78	12.83	10.02
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	140.64	1.69	4.66	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	107.46	2.96	1.69	0.42
stomach, fetal, donor1	10062-101H8	83.30	2.14	4.27	1.07
submaxillary gland, adult	10202-103F4	58.68	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	80.59	2.28	2.28	0.62
substantia nigra, adult, donor10258	10371-105G2	86.38	2.07	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	70.66	2.12	3.53	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	115.78	3.67	4.13	0.69
temporal lobe, adult, pool1	10031-101E4	131.48	8.14	3.98	1.86
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	166.67	2.14	4.99	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	146.37	2.20	4.40	0.00
tenocyte, donor1	11763-123H8	95.30	2.09	2.09	0.00
tenocyte, donor2	11765-123I1	64.09	2.29	1.14	0.00
tenocyte, donor3	11768-123I4	116.39	3.34	3.34	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	182.54	5.95	9.18	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	104.97	2.00	4.01	0.46
teratocarcinoma cell line:PA-1	10807-111A6	167.22	5.58	4.65	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	123.39	4.06	7.74	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	116.48	2.27	9.45	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	102.41	3.38	2.73	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	134.19	4.23	5.54	2.28
testis, adult, pool1	10026-101D8	95.56	7.95	3.22	2.15
testis, adult, pool2	10096-102C6	112.77	6.77	6.77	1.80
thalamus - adult, donor10196	10168-103B6	94.94	6.62	5.52	0.00
thalamus, adult, donor10252	10154-103A1	85.80	2.19	2.97	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	58.51	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	93.05	4.45	4.28	1.32
thalamus, newborn, donor10223	10366-105F6	137.50	8.05	7.48	0.58
throat, adult	10209-103G2	74.90	2.75	0.75	0.50
throat, fetal, donor1	10061-101H7	88.36	2.13	2.13	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	164.15	6.16	1.19	0.79
thymus, adult, pool1	10027-101D9	65.91	0.99	2.49	0.20
thymus, fetal, pool1	10043-101F7	72.84	1.35	3.22	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	193.59	6.78	5.72	1.86
thyroid carcinoma cell line:TCO-1	10783-110G9	92.89	3.63	3.07	1.12
thyroid, adult, pool1	10028-101E1	118.69	1.77	1.96	0.37
thyroid, fetal, donor1	10060-101H6	107.84	2.64	4.48	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	0.00	0.00	0.00
tongue, adult	10203-103F5	92.80	4.19	1.63	1.16
tongue, fetal, donor1	10059-101H5	60.69	1.97	1.18	0.00
tonsil, adult, pool1	10047-101G2	99.07	3.21	1.70	1.00
trachea, adult, pool1	10029-101E2	79.02	2.94	1.80	0.57
trachea, fetal, donor1	10058-101H4	73.86	4.62	1.54	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	174.30	8.86	3.54	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	222.39	5.78	6.08	1.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	104.20	3.13	2.35	1.10
tridermal teratoma cell line:HGRT	10694-109G1	93.22	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	123.67	3.05	2.37	0.59
umbilical cord, fetal, donor1	10057-101H3	79.29	2.09	4.17	0.00
uterus, adult, pool1	10100-102D1	90.94	4.78	2.39	1.54
uterus, fetal, donor1	10055-101H1	99.31	3.58	2.05	0.51
vagina, adult	10204-103F6	66.56	3.88	0.65	0.65
vein, adult	10191-103E2	55.68	2.63	0.88	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	36.58	0.80	0.80	0.00